Pacific Health Care Organization 2026: Revenue $1.51M, EPS $0.03— 10-Q Summary

Pacific Health Care Organization reported 2026 nine-month revenue of $1.51M, down 4.7% YoY, while net income rose 50% to $334.61K and EPS increased to $0.03. Revenue declines were seen in HCO and MPN, offset by growth in medical bill review and utilization review.

Original reporting
Published Nov 3, 2026, 9:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Pacific Health Care Organization 2026: Revenue $1.51M, EPS $0.03— 10-Q Summary — source image
Decision brief

The 30-second read

$PFHONeutralLow
01

Why it matters

The report provides fresh data for a micro‑cap health‑services firm, offering limited but actionable insight for short‑term traders.

02

Market read

First disclosure of Q3 numbers for a micro‑cap health‑services company; modest trading relevance.

03

What to watch

Potential cost‑cutting measures and new program launches may improve margins in Q4.

Relevance 6/10Novelty 6/10Timing: after‑hours release

Background

Pacific Health Care Organization filed its 2026 nine‑month 10‑Q, highlighting mixed financial performance.

Company-level read

Ticker impact

$PFHONeutralMedium confidence
Context

10-Q disclosed nine‑month revenue down 4.7% and net income up 50%, providing the first public numbers for the period.

Expected impact

likely modest downside as investors weigh lower revenue against higher profit

Evidence & confidence

The mixed results (down revenue, up earnings) create uncertainty; micro‑cap liquidity suggests limited move.

Market effects

Healthcare services sector may see slight pressure as revenue contraction signals demand softness.

U.S. micro‑cap market sees modest activity; no broader regional effect.

Limited to niche investors; no global market impact.

Counterpoint

The 50% earnings surge could be a buying opportunity if the market overreacts to revenue decline.

Key entities

  • Pacific Health Care Organization

    Healthcare services provider reporting Q3 results.

Related articles

$VACHighAI 8/10

What Marriott Vacations Worldwide (VAC) Said on Its Q3 Earnings Call

Marriott Vacations Worldwide (VAC) reported Q3 earnings, highlighting a 4% increase in North American tours and a 43% rise in owner VPG. The company expects Q4 contract sales of $599M-$619M and adjusted EBITDA of $218M-$238M. Hurricane damage delayed the sale of a Kauaʻi property, impacting Q4 profits. VAC also announced a $322M share repurchase extension and plans to discuss growth strategies at an investor day.

$UWMCMed

UWM Q3 Earnings Call Highlights

UWM Holdings (UWMC) reported Q3 earnings, with CEO Ishbia discussing mortgage servicing rights (MSR) sales, leverage, and Q4 outlook. MSR sales are expected to be $135B-$140B in 2026, down from $180B in 2025. Leverage is targeted below 1.5 by year-end, with potential to reach 1.2-1.3. Q4 loan volume is not expected to exceed recent levels, and gain on sale is projected within 115-130 range.

$USPHMedAI 8/10

U.S. Physical Therapy Q3 Earnings Call Highlights

U.S. Physical Therapy (USPH) reported Q3 earnings, with adjusted physical therapy margins rising 60 basis points YoY to 19%, despite higher medical costs. The company plans acquisitions and clinic expansions. Industrial injury prevention revenue grew 14% to $33M. GAAP net income fell to $11M from $13M YoY. USPH ended Q3 with $38M in cash and $247M in borrowings.

$UVVMed

Universal Q2 Earnings Call Highlights

Universal Corp. (UVV) reported Q2 earnings, with CEO Preston Wigner noting a decline in uncommitted inventory to 19% and expectations for further reduction. Management anticipates improved tobacco operating margins with increased shipments. Ingredients Operations revenue fell 8% to $88M, with an operating loss of $2M. Net debt rose to $1.15B, but liquidity remains strong at $945M. The company plans to reduce debt as the tobacco market moves into oversupply.